kabutan

TAIKO PHARMACEUTICAL CO., LTD., January-September (Third Quarter Cumulative) Ordinary Profit Turns to Profit, Exceeds Full-Year Plan

Fri Nov 8, 2024 3:30 pm JST Earnings

4574 TAIKO PHARMACEUTICAL CO., LTD. 【J-GAAP】

Earnings Report

TAIKO PHARMACEUTICAL CO., LTD. <4574> [TSE-P] announced its financial results after the market closed on November 8th (15:30). The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending December 2024 (January to September) turned into a profit of 705 million yen (compared to a loss of 589 million yen in the same period last year). The progress rate against the full-year plan of 590 million yen is 119.5%.

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary loss for the October to December period (4Q) is expected to further decrease to loss of 115 million yen (compared to a loss of 659 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit/loss turned to a profit of profit of 177 million yen (compared to a loss of 79 million yen in the same period last year). The operating profit/loss margin drastically improved from -2.5% in the same period last year to 14.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 3,389 -2,750 -2,898 -3,182 -73.0 ー Nov 11, 2022 J-GAAP
Jan - Sep, 2023 4,417 -444 -589 -562 -12.1 ー Nov 10, 2023 J-GAAP
Jan - Sep, 2024 4,579 726 705 714 14.2 119.5 Nov 8, 2024 J-GAAP
YoY +3.7% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 3,632 -609 -738 -3,097 -65.4 0 Feb 9, 2024 J-GAAP
Jul - Dec, 2024 Guidance 3,940 68 62 -214 -4.3 － Aug 9, 2024 J-GAAP
YoY +8.5% － － +93.1% +93.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 5,040 -3,079 -3,352 -4,895 -112.3 0 Feb 10, 2023 J-GAAP
Dec, 2023 6,120 -1,005 -1,248 -3,611 -76.3 0 Feb 9, 2024 J-GAAP
Dec, 2024 Guidance 6,800 550 590 550 11.0 － Aug 9, 2024 J-GAAP
YoY +11.1% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 1,929 -48 -79 -48 -1.0 -2.5 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 1,703 -561 -659 -3,049 -64.4 -32.9 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 1,377 214 229 472 9.4 15.5 May 10, 2024 J-GAAP
Apr - Jun, 2024 1,483 268 299 292 5.8 18.1 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 1,719 244 177 -50 -1.0 14.2 Nov 8, 2024 J-GAAP
YoY -10.9% － － -4.2% +2.9%

Related Articles